 SAN DIEGO COPENHAGEN, Denmark--BUSINESS WIRE--- ORPH Shareholder--Shareholder rights law firm Robbins LLP announces that a class action has been filed on behalf of all purchasers of Orphazyme AS NASDAQ: ORPH American Depository Shares ADSs 1 in or traceable to the Companys September 2020 initial public offering IPO for remedies under the Securities Act of 1933, and 2 between September 29, 2020 and June 18, 2021 for remedies under the Securities Exchange Act of 1934. Orphazyme is a biopharmaceut 